Torrent Research Centre
Innovating For A Healthier Tomorrow
Environmentally Responsible
Green Ambience. Green Energy. Green Air.
Global Presence
Growing Operations in 40+ Countries
Empowering Society
REACH Movement has impacted more than 1,24,000 Children
Not Just Healthcare... Lifecare.
Business Areas
India
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
International
With significant presence in more than 50 countries, Torrent is all poised to spread wings across globe with strong technical capabilities and international accreditations. To enable strategic differentiation, Torrent Pharma’s international business is segregated into US, UK, Germany, Europe, Brazil and Rest of the World.
Products
Therapeutic Areas
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
Product/Prescribing Information
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
Report Adverse Event /
दवाओं का दुष्प्रभाव रिपोर्टिंग
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
Quick Facts
8
Manufacturing Plants
750 +
Scientists
2000 +
Product Registrations
Presence in 50 +
Countries
News & Events
Quarterly Results
Torrent Pharma announces Q2 FY25 Results click here
Press Release
Torrent Pharmaceuticals Limited (Torrent) refutes claims of Shelcal 500 allegedly failing CDSCO quality test click here
Quarterly Results
Torrent Pharma announces Q1 FY25 Results click here
Agreement
Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India click here
Quarterly Results
Torrent Pharma announces Q4 FY24 Results click here
TPL NLEM Price Revision
Torrent Pharmaceuticals Ltd has reduced the MRP of NLEM product click here
Quarterly Results
Torrent Pharma announces Q3 FY24 Results click here
Agreement
Torrent and Zydus sign licensing agreement click here
Quarterly Results
Torrent Pharma announces Q2 FY24 Results click here
EIR from US FDA for Dahej facility
Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility click here
Quarterly Results
Torrent Pharma announces Q1 FY24 results click here
NLEM Price Revision
Torrent Pharmaceuticals Ltd has reduced the MRP of NLEM product click here
Quarterly Results
Torrent Pharma announces Q4 FY23 results click here
NLEM Price Revision
Torrent Pharmaceuticals Ltd. has reduced the MRP of NLEM Products click here
NLEM Price Revision
Curatio Healthcare (I) Pvt Ltd. (A Torrent Pharmaceuticals Ltd Subsidiary ) has reduced the MRP of NLEM product click here
NLEM Price Revision
Torrent Pharmaceutical Ltd. has reduced the MRP of NLEM Products click here
Quarterly Results
Torrent Pharma announces Q3 FY23 results click here
Agreement
Torrent Pharmaceuticals Ltd enters into co-marketing partnership click here
Quarterly Results
Torrent Pharma announces Q2 FY23 Results click here
Acquisition
Torrent Pharma to acquire Curatio Healthcare click here
Quarterly Results
Torrent Pharma announces Q1 FY23 results click here
Agreement
Torrent Pharma acquires 4 Brands from Dr.Reddy’s laboratories click here
Quarterly Results
Torrent Pharma announces Q4 FY22 results click here
Agreement
Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment click here
Quarterly Results
Torrent Pharma announces Q3 FY22 results click here
Product Launch
Torrent Pharma to launch Molnupiravir under the brand name Molnutor® in India click here
Quarterly Results
Torrent Pharma announces Q2 FY22 results click here
Quarterly Results
Torrent Pharma announces Q1 FY22 results click here
Agreement
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19 click here
Quarterly Results
Torrent Pharma announces Q4 FY21 results click here
Agreement
Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India click here
Quarterly Results
Torrent Pharma announces Q3 FY21 results click here
Quarterly Results
Torrent Pharma announces Q2 FY21 results click here
Quarterly Results
Torrent Pharma announces Q1 FY21 results click here
Revenue Q1 FY 20-21
Torrent Pharma reports its Revenue Q1 FY 20-21 click here